mhurhangee/ep-ind-claims huggingface dataset:
A method of layer-by-layer deposition of a plurality of layers of material onto the wall or walls of a channel of a microfluidic device, the method comprising: loading a tube with a series of segments of solution, a said segment of solution bearing a material to be deposited; coupling said tube to said microfluidic device; and injecting said segments of solution into said microfluidic device such that said segments of solution pass, in turn, through said channel depositing successive layers of material to perform said layer-by-layer deposition onto said wall or walls of said channel. loading a tube with a series of segments of solution, a said segment of solution bearing a material to be deposited; coupling said tube to said microfluidic device; and injecting said segments of solution into said microfluidic device such that said segments of solution pass, in turn, through said channel depositing successive layers of material to perform said layer-by-layer deposition onto said wall or walls of said channel.
A packer, comprising: a mandrel; a packing element disposed circumferentially around an outer surface of the mandrel and arranged to be expanded into engagement with a tubular as a result of the application of an axial compressive force creating a relative movement between the mandrel and an actuation sleeve; and a boosting assembly (131a,b) disposed on the outer surface of the mandrel; wherein the boosting assembly (131a,b) comprises a housing (133a,b), a booster sleeve (134a,b), and a sealed pressure chamber (127a,b) defined by the housing (133a,b) and the booster sleeve (134a,b), and wherein the boosting assembly (131a,b) is coupled to a lower end of the packer, a fluid path (142a,b) existing between the boosting assembly (131a,b) and the lower end of the packer; wherein the booster sleeve (134a,b) is arranged to be movable toward the packing element as a result of an increase in a pressure surrounding the packer, wherein the increase in pressure is communicated to the booster sleeve (134a,b) via the fluid path (142a,b), after the packing element has been expanded into engagement with the tubular, to thereby exert a force on the packing element and decrease a volume of the pressure chamber (127a,b); and wherein the booster sleeve (134a,b) is moveable independently of the actuation sleeve. a mandrel; a packing element disposed circumferentially around an outer surface of the mandrel and arranged to be expanded into engagement with a tubular as a result of the application of an axial compressive force creating a relative movement between the mandrel and an actuation sleeve; and a boosting assembly (131a,b) disposed on the outer surface of the mandrel; wherein the boosting assembly (131a,b) comprises a housing (133a,b), a booster sleeve (134a,b), and a sealed pressure chamber (127a,b) defined by the housing (133a,b) and the booster sleeve (134a,b), and wherein the boosting assembly (131a,b) is coupled to a lower end of the packer, a fluid path (142a,b) existing between the boosting assembly (131a,b) and the lower end of the packer; wherein the booster sleeve (134a,b) is arranged to be movable toward the packing element as a result of an increase in a pressure surrounding the packer, wherein the increase in pressure is communicated to the booster sleeve (134a,b) via the fluid path (142a,b), after the packing element has been expanded into engagement with the tubular, to thereby exert a force on the packing element and decrease a volume of the pressure chamber (127a,b); and wherein the booster sleeve (134a,b) is moveable independently of the actuation sleeve.
A method for evaluating the service life of a bearing, which comprises the following: obtaining the current working condition of the bearing; acquiring a current vibration signal of the bearing in the current working condition, and calculating a current vibration value of the bearing, characterised by obtaining a current surface scaling area of the bearing corresponding to the current vibration value of the bearing and a current scaling rate of the bearing in the current working condition; and obtaining a remaining service life of the bearing based on the current surface scaling area of the bearing and the current scaling rate of the bearing. obtaining the current working condition of the bearing; acquiring a current vibration signal of the bearing in the current working condition, and calculating a current vibration value of the bearing, characterised by obtaining a current surface scaling area of the bearing corresponding to the current vibration value of the bearing and a current scaling rate of the bearing in the current working condition; and obtaining a remaining service life of the bearing based on the current surface scaling area of the bearing and the current scaling rate of the bearing.
A method for predicting the clinical response to a cancer viral-based vaccine in a patient having cancer comprising: providing a serum sample from a patient who has not been previously administered the cancer vaccine; assaying the serum sample to determine the levels of antibodies in the patient to at least one glycan and/or glycoprotein antigen selected from the group consisting of Sialylα2-6Galβ1-4Glc-(6'SLac), Sialylα2-3Galβ1-4(Fucα1-3)GlcNAc- (SLeX), Sialylα2-3Galβ1-4Glc-, Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ- (BG-H1), GalNAcβ1-4Galβ- (GA2di), Galβ1-4GlcNAcβ1-6(Galβ1-4GlcNAcβ1-3)Galβ- (LNnH), Gala1-3Gal- (Bdi), Ac-Ser-(GalNAcα)Thr-Gly-Gly- (Ac-S-Tn(Thr)-G-G), BSM, Lactose, Galβ1-3GlcNAcβ1-3Galβ-, Fuc-b, Fuc-a, Galβ1-6Man-α-(Galb1-6Man-a), Galβ1-3GalNAcβ1-4Galβ1-, Galα1-4Galβ- (Gala1-4Galb), Manα1-6[Manα1-3]Manβ- (ManT), Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1- (pLNH), Rha-α-, GalNAcα1-3Galβ- (Adi), GalNAcα1-3(Fucα1-2)Galβ- (BG-A), Galβ1-3GalNAcβ1-4Galβ1-, fetuin, and Ac-Ser-(GalNAcα)Ser-Ser-Gly- (Ac-S-Tn(Ser)-S-G); and comparing the determined levels of antibodies to the at least one glycan and/or glycoprotein antigen to a control, so as to predict the clinical response to the cancer vaccine in the patient. providing a serum sample from a patient who has not been previously administered the cancer vaccine; assaying the serum sample to determine the levels of antibodies in the patient to at least one glycan and/or glycoprotein antigen selected from the group consisting of Sialylα2-6Galβ1-4Glc-(6'SLac), Sialylα2-3Galβ1-4(Fucα1-3)GlcNAc- (SLeX), Sialylα2-3Galβ1-4Glc-, Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ- (BG-H1), GalNAcβ1-4Galβ- (GA2di), Galβ1-4GlcNAcβ1-6(Galβ1-4GlcNAcβ1-3)Galβ- (LNnH), Gala1-3Gal- (Bdi), Ac-Ser-(GalNAcα)Thr-Gly-Gly- (Ac-S-Tn(Thr)-G-G), BSM, Lactose, Galβ1-3GlcNAcβ1-3Galβ-, Fuc-b, Fuc-a, Galβ1-6Man-α-(Galb1-6Man-a), Galβ1-3GalNAcβ1-4Galβ1-, Galα1-4Galβ- (Gala1-4Galb), Manα1-6[Manα1-3]Manβ- (ManT), Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1- (pLNH), Rha-α-, GalNAcα1-3Galβ- (Adi), GalNAcα1-3(Fucα1-2)Galβ- (BG-A), Galβ1-3GalNAcβ1-4Galβ1-, fetuin, and Ac-Ser-(GalNAcα)Ser-Ser-Gly- (Ac-S-Tn(Ser)-S-G); and comparing the determined levels of antibodies to the at least one glycan and/or glycoprotein antigen to a control, so as to predict the clinical response to the cancer vaccine in the patient.
A method of transmitting channel information, which is transmitted by a user equipment in a wireless communication system, comprising: receiving a 1st reference signal transmitted in accordance with a 1st transmission period from a base station; receiving a 2nd reference signal transmitted in accordance with a 2nd transmission period from the base station; and performing channel estimation using the 1st reference signal and performing channel estimation using the 2nd reference signal, wherein the channel estimation performed using the 1st reference signal and the channel estimation performed using the 2nd reference signal are transmitted to the base station time-division multiplexed together or one of the channel estimation performed using the 1st reference signal and the channel estimation performed using the 2nd reference signal is dropped in order not to overlap determined timing points to transmit the channel estimation performed using the 1st reference signal and the channel estimation performed using the 2nd reference signal, and wherein the 1st reference signal includes a cell-common reference signal, CRS, and wherein the 2nd reference signal includes a channel state information reference signal, CSI-RS. receiving a 1st reference signal transmitted in accordance with a 1st transmission period from a base station; receiving a 2nd reference signal transmitted in accordance with a 2nd transmission period from the base station; and performing channel estimation using the 1st reference signal and performing channel estimation using the 2nd reference signal, wherein the channel estimation performed using the 1st reference signal and the channel estimation performed using the 2nd reference signal are transmitted to the base station time-division multiplexed together or one of the channel estimation performed using the 1st reference signal and the channel estimation performed using the 2nd reference signal is dropped in order not to overlap determined timing points to transmit the channel estimation performed using the 1st reference signal and the channel estimation performed using the 2nd reference signal, and wherein the 1st reference signal includes a cell-common reference signal, CRS, and wherein the 2nd reference signal includes a channel state information reference signal, CSI-RS.
A sustained release formulation of methotrexate for use in treating or reducing the risk of proliferative vitreoretinopathy or epiretinal membranes in a subject, wherein the methotrexate is intravitreally administered over at least a three-month period, or, is released over at least a three-month period by a device that is implanted into the eye of the subject.
An apparatus for obtaining a bodily-fluid sample from a patient, the apparatus comprising: a distribution member forming at least a portion of a pre-sample reservoir and defining a fluid flow path in fluid communication with an outlet; and a flow controller in fluid communication with the distribution member and configured to be placed in fluid communication with the patient, the flow controller having a first configuration in which the flow controller is in fluid communication with the pre-sample reservoir to transfer a first volume of bodily-fluid from the patient to the pre-sample reservoir, the flow controller configured to transition from the first configuration to a second configuration after the first volume of bodily-fluid is transferred into the pre-sample reservoir to sequester the first volume in the pre-sample reservoir and transfer a second volume of bodily-fluid to the fluid flow path, the distribution member configured to be coupled to a sample reservoir after the second volume of bodily-fluid is transferred into the fluid flow path, the outlet configured to place the fluid flow path in fluid communication with the sample reservoir when the distribution member is coupled to the sample reservoir to transfer a sample volume of bodily-fluid from the fluid flow path into the sample reservoir. a distribution member forming at least a portion of a pre-sample reservoir and defining a fluid flow path in fluid communication with an outlet; and a flow controller in fluid communication with the distribution member and configured to be placed in fluid communication with the patient, the flow controller having a first configuration in which the flow controller is in fluid communication with the pre-sample reservoir to transfer a first volume of bodily-fluid from the patient to the pre-sample reservoir, the flow controller configured to transition from the first configuration to a second configuration after the first volume of bodily-fluid is transferred into the pre-sample reservoir to sequester the first volume in the pre-sample reservoir and transfer a second volume of bodily-fluid to the fluid flow path, the distribution member configured to be coupled to a sample reservoir after the second volume of bodily-fluid is transferred into the fluid flow path, the outlet configured to place the fluid flow path in fluid communication with the sample reservoir when the distribution member is coupled to the sample reservoir to transfer a sample volume of bodily-fluid from the fluid flow path into the sample reservoir.
An applicator device (1; 3; 4; 5; 6) for applying a fluid or pasty product to keratin fibres or to the skin (epidermis), comprising an elongate core extending along a longitudinal axis X and having a longitudinal cylindrical shape, a plurality of spurs (10; 110; 210; 310; 410; 510; 610; 710) distributed on said core, each spur extending from an anchoring end in the core to a free end and being as a single piece with said core, each spur including, at the free end, means for capturing and retaining a quantity of fluid or pasty product, characterised in that, from the anchoring end, each spur includes a first body segment (16;216) curved in a first direction, and then a second body segment (18;218;518) curved in an opposite direction, and then terminates at the free end, so as to give each spur an inverted "S" shape.
A polypropylene composition having a melt flow rate MFR 2 (230 °C) measured according to according to ISO 1133 of at least 2.0 g/10min, said polypropylene composition comprises a propylene copolymer (C-PP), a high melt strength polypropylene (HMS-PP), and an α-nucleating agent, wherein the propylene copolymer (C-PP) (a) has a comonomer content of equal or below 7.0 wt.-%, the comonomers are ethylene and/or at least one C 4 to C 12 α-olefin, (b) comprises two propylene copolymer fractions and, wherein the comonomer content of the first propylene copolymer fraction is in the range of 1.0 to 4.5 wt.-% and the comonomer content of the first propylene copolymer fraction is lower compared to the comonomer content of the second propylene copolymer fraction, and wherein the high melt strength polypropylene (HMS-PP) has a branching index g' of less than 1.0. (a) has a comonomer content of equal or below 7.0 wt.-%, the comonomers are ethylene and/or at least one C 4 to C 12 α-olefin, (b) comprises two propylene copolymer fractions and, wherein the comonomer content of the first propylene copolymer fraction is in the range of 1.0 to 4.5 wt.-% and the comonomer content of the first propylene copolymer fraction is lower compared to the comonomer content of the second propylene copolymer fraction, and
Administration system in film form for transmucosal administration of a steroid hormone, comprising 5% by weight of a steroid hormone from the group consisting of testosterone, 7α-methyl-19-nortestosterone and 7α-methyl-11β-fluoro-19-nortestosterone and 95% by weight of hydroxypropylmethylcellulose (HPMC), wherein the steroid hormone is present dissolved in the carrier material, characterized in that it dissolves completely in a period of less than 30 minutes in the mouth.
A method comprising: receiving, by a validation entity computer, an authentication code, wherein the authentication code includes a non-encrypted portion and an encrypted portion; decrypting, by the validation entity computer, the encrypted portion of the authentication code to obtain access data; and initiating, by the validation entity computer, provisioning the access data to a mobile device; wherein the non-encrypted portion comprises a key index, the key index being used for identifying a key used to decrypt the encrypted portion. receiving, by a validation entity computer, an authentication code, wherein the authentication code includes a non-encrypted portion and an encrypted portion; decrypting, by the validation entity computer, the encrypted portion of the authentication code to obtain access data; and initiating, by the validation entity computer, provisioning the access data to a mobile device; wherein the non-encrypted portion comprises a key index, the key index being used for identifying a key used to decrypt the encrypted portion.
A lumbar support assembly comprising: a mat formed by connecting wires (230, 240, 260) in such a manner as to take shape in the form of a net and connected to a seat frame in such a manner as to be rotatable forward or backward; a tension unit comprising first and second cables (410, 420), respective first end portions of the first and second cable (410, 420) being connected to opposite sides, respectively, of the seat frame, and respective second end portions thereof extending to the mat; a drive unit mounted on a center lower portion of the mat and connected to the respective second end portions of the first and second end portions, the drive unit being configured to pull or release the first and second cables (410, 420); and a mounting clip unit (290, 295), a first end portion of the mounting clip unit (290, 295) being formed to a shape of a cylinder that extends toward opposite lateral sides and being combined with the mat, and a second end portion thereof being formed in such a manner that opposite end parts of the first end portion protrude backward and are combined in a hooked manner with the drive unit. a mat formed by connecting wires (230, 240, 260) in such a manner as to take shape in the form of a net and connected to a seat frame in such a manner as to be rotatable forward or backward; a tension unit comprising first and second cables (410, 420), respective first end portions of the first and second cable (410, 420) being connected to opposite sides, respectively, of the seat frame, and respective second end portions thereof extending to the mat; a drive unit mounted on a center lower portion of the mat and connected to the respective second end portions of the first and second end portions, the drive unit being configured to pull or release the first and second cables (410, 420); and a mounting clip unit (290, 295), a first end portion of the mounting clip unit (290, 295) being formed to a shape of a cylinder that extends toward opposite lateral sides and being combined with the mat, and a second end portion thereof being formed in such a manner that opposite end parts of the first end portion protrude backward and are combined in a hooked manner with the drive unit.
An air battery, comprising: a cell frame of an insulating material having a bottomed frame shape, in which an electrolytic solution and an anode are stored; a cathode that is disposed opposite the anode across the electrolytic solution stored in the cell frame; and a current collecting member that is electrically connected to the anode, characterized in that: the anode and the current collecting member are connected to each other via a plurality of electrically conducting members that penetrate a bottom of the cell frame, and the current collecting member serves as a spacer to form a ventilation space between adjacent air batteries. a cell frame of an insulating material having a bottomed frame shape, in which an electrolytic solution and an anode are stored; a cathode that is disposed opposite the anode across the electrolytic solution stored in the cell frame; and a current collecting member that is electrically connected to the anode, characterized in that: the anode and the current collecting member are connected to each other via a plurality of electrically conducting members that penetrate a bottom of the cell frame, and the current collecting member serves as a spacer to form a ventilation space between adjacent air batteries. the anode and the current collecting member are connected to each other via a plurality of electrically conducting members that penetrate a bottom of the cell frame, and the current collecting member serves as a spacer to form a ventilation space between adjacent air batteries.
A method for Diameter signaling message external identifier address resolution and routing, the method comprising: at a Diameter signaling router, DSR, including at least one processor (200, 202, 204, 206): receiving a Diameter signaling message; decoding the Diameter signaling message and determining that an external identifier attribute value pair, AVP, is present in the Diameter signaling message; in response to determining that an external identifier AVP is present in the Diameter signaling message, decoding contents of the external identifier AVP; performing a lookup in a domain table using a domain identifier component of the external identifier AVP and locating an entry corresponding to the domain identifier; determining whether a local identifier table is configured for the domain identifier component; in response to determining that the local identifier table is configured for the domain identifier component, performing a lookup in the local identifier table using a local identifier component of the external identifier AVP; populating at least one Diameter routing AVP of the Diameter signaling message with Diameter routing information obtained from the lookup in the domain table or the lookup in the local identifier table; and routing (312, 314) the Diameter signaling message using the Diameter routing information receiving a Diameter signaling message; decoding the Diameter signaling message and determining that an external identifier attribute value pair, AVP, is present in the Diameter signaling message; in response to determining that an external identifier AVP is present in the Diameter signaling message, decoding contents of the external identifier AVP; performing a lookup in a domain table using a domain identifier component of the external identifier AVP and locating an entry corresponding to the domain identifier; determining whether a local identifier table is configured for the domain identifier component; in response to determining that the local identifier table is configured for the domain identifier component, performing a lookup in the local identifier table using a local identifier component of the external identifier AVP; populating at least one Diameter routing AVP of the Diameter signaling message with Diameter routing information obtained from the lookup in the domain table or the lookup in the local identifier table; and routing (312, 314) the Diameter signaling message using the Diameter routing information
A method of responding to excess power generation of a fuel cell power plant occasioned by a load power reduction transition from a first level of power demanded by a load, to a second level of power demanded by said load, said second level being lower than said first level, by connecting the voltage output of fuel cells of the power plant to at least one fuel cell voltage limiting device, characterized in that the connection is performed for a period of time in response to a positive time derivative of voltage of at least one of the fuel cells in the power plant exceeding a predetermined limiting value, wherein said period of time extends until the power output of the fuel cell power plant reaches a predetermined power goal which is an interim power goal which is between said first level of power and said second level of power.